TG Therapeutics Inc (TGTX)
US$ 33.64-0.65%
Price Chart
Key Statistics
Market Cap
$ 5.3B
P/E Ratio
133.48
Revenue (TTM)
$ 386.39M
Volume
2.21M
52W High
$ 46.48
52W Low
$ 15.16
Dividend Yield
0.00%
Beta
2.21
Technicals
50-Day MA
38.7868
200-Day MA
30.1862
52 Week High
46.48
52 Week Low
15.16
About TGTX
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United State.
Employees
338
Headquarters
Morrisville, NC
CEO
Mr. Michael S. Weiss Esq.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg